中国中免：公司为上海和香港两地上市公司

Group 1 - The core viewpoint of the article is that China National Pharmaceutical Group (China National Immunization) clarified its total market capitalization, which is the sum of its market values from both Shanghai and Hong Kong listings [1] Group 2 - The company responded to investor inquiries on its interactive platform regarding its dual listing status [1] - The total market capitalization reflects the company's valuation across two major financial markets [1]